Skip to main content
. 2011 Feb 1;17(2):BR35–BR41. doi: 10.12659/MSM.881383

Figure 3.

Figure 3

GLP-1 markedly increased KDR, Flt-1, VE-cadherin and eNOS mRNA Levels in a dose-dependent manner.1: Control group, 2: GLP-1 1 nM group; 3: GLP-1 10 nM group; 4: GLP-1 20 nM group.

HHS Vulnerability Disclosure